Sensory neuropathy (loss of protective sensation) is one of the strongest risk factors for both foot
ulceration and amputation in a patient with diabetes. Nerve damage associated with diabetes involves axonal
degeneration of myelinated and unmyelinated nerves and involves loss of both small and large nerve fibers.
The diagnosis of diabetic sensory neuropathy is made based on review of the signs and symptoms,
the results of the physical examination and diagnostic studies. Dr. Lavery reminds us that the use of a single
instrument (Semmes-Weinstein monofilaments, for example), is not sufficient to make a definitive diagnosis. Patients with nutritional deficiencies, anemia,
radiculopathies, alcoholism and other conditions present with symptoms very similar to diabetic sensory neuropathy.
Dr. Lavery reviews the various screening tests that will
help the practitioner make a correct
diagnosis. Standard vibration perception, deep tendon reflexes, motor strength, sharp/dull discrimination and
light touch should all be part of the
initial examination. While these tests are valuable, their results are difficult to quantify.
The biothesiometer is a unique device which can provide semi-quantitative information about the level of
vibration the patient can feel in their foot.
The information gleaned from this device helps us better understand the benefits and effectiveness of our
treatment.

Monochromatic Near-Infrared Therapy, commonly known as Anodyne, has shown great promise. 98%
of patients who received Anodyne Therapy for thirty minutes, three
times weekly, had improvement after six weeks. The percentage of patients who saw improvement increased to one hundred percent, after twelve
weeks of treatment.
Dr. Lavery also discusses surgical decompression. This technique has shown great promise. However, he feels that more research is needed before
it is used on a
widespread basis in this high risk population.
Be aware - The answer to the question, "Can you do anything for the numbness and burning in my foot?", is
rapidly changing.